DRL closes acquisition of Habitrol brand from Novartis Usha Sharma Dec 19, 2014 Dr Reddy’s Laboratories (DRL) has closed the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy…
DRL launches docetaxel injection in US EP News Bureau Nov 25, 2014 Docetaxel injection USP, 20 mg/mL and 80 mg/4 mL are available as a single dose
Dr Reddy’s launch fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release… EP News Bureau Nov 20, 2014 They are available in a 20 count blister
